Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy

M. Melato, G. Tuveri

Research output: Contribution to journalArticlepeer-review


Two women, 65 and 55 years old, with metastatic malignant melanoma, were treated with low doses of BCNU for a short period (six and three months, total dose 2500 and 2000 mg). Both patients developed pulmonary fibrosis, which was visible in postmortem examination. In the first woman, lesion development was so widespread as to be considered responsible for death. Because chest x-ray before tractment was not abnormal, the authors consider BCNU capable of inducing the lesion.

Original languageEnglish
Pages (from-to)1311-1314
Number of pages4
Issue number6
Publication statusPublished - 1980

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy'. Together they form a unique fingerprint.

Cite this